Overview
- Health officials scheduled a national mobilization for Saturday, Nov. 8 to intensify household prevention and management actions against Aedes aegypti.
- Minister Alexandre Padilha said Anvisa is in final review and he expects registration of Instituto Butantan’s single-dose dengue vaccine by year-end, with target groups to be defined by the National Immunization Program after approval.
- The Butantan vaccine dossier covers ages 2 to 59, and the government projects up to 40 million doses in 2026 produced at scale by WuXi Biologics.
- The ministry plans to expand vector-control tools, projecting Wolbachia releases in 44 municipalities in 2026 and additional deployments in 13 cities this year, while scaling Dissemination Stations of Larvicides from 77,000 units in 26 cities to all municipalities over 50,000 residents next year.
- Surveillance data show 1.61 million probable cases and 1,688 deaths in 2025 to date—reductions of roughly 75% and 72% versus 2024—yet a survey found about 30% of 3,200 municipalities on alert, prompting Força Nacional teams, hydration centers, and supplies backed by nearly R$184 million.